Cardiovascular Death Risk in Primary Central Nervous System Lymphoma Patients Treated With Chemotherapy: A Registry-Based Cohort Study

• Published in: Frontiers in oncology Vol. 11; p. 641955
• Main Authors: Guan, Tianwang, Qiu, Zicong, Su, Miao, Yang, Jinming, Tang, Yongshi, Jiang, Yanting, Yao, Dunchen, Lai, Yanxian, Li, Yanfang, Liu, Cheng
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 11.05.2021
• Subjects: cardio-oncology; cardiovascular death; chemotherapy; non-central nervous system lymphoma; Oncology; primary central nervous system lymphoma; SEER; SEER; cardiovascular death; cardio-oncology; chemotherapy; non-central nervous system lymphoma; primary central nervous system lymphoma

To study the cardiovascular death (CVD) risk in primary central nervous system lymphoma (PCNSL) patients with chemotherapy. We obtained 2,020 PCNSL participants and 88,613 non-central nervous system lymphoma (NCNSL) participants with chemotherapy from Surveillance, Epidemiology, and End Results (SEE...